Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Infertility Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global infertility drugs market reached a value of US$ 3.47 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.95 Billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive. 

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Infertility Drugs Market Trends:

Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility drugs market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, route of administration, distribution channel and end user.

Breakup by Drug Class:

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Gonadotropin
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Biguanides
  • Others
     

Breakup by Route of Administration:

  • Oral
  • Intravenous
  • Subcutaneous
  • Intramuscular
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
     

Breakup by End User:

  • Male
  • Female
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Drug Class, Route of Administration, Distribution Channel, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global infertility drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global infertility drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global infertility drugs market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Infertility Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Class
    6.1    Gonadotropin
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Aromatase Inhibitors
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Selective Estrogen Receptor Modulators (SERMs)
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Biguanides
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intravenous
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Subcutaneous
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Intramuscular
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by End User
    9.1    Male
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Female
        9.2.1 Market Trends
        9.2.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
        15.3.2    Bayer AG
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Ferring Pharmaceuticals
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Livzon Pharmaceutical Group Inc. 
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Mankind Pharma
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Merck & Co. Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Merck KGaA
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Novartis AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Pfizer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
        15.3.10    Sanofi S.A.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Theramex
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2021
Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2021
Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2021
Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2021
Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Infertility Drugs Market: Competitive Structure
Table 8: Global: Infertility Drugs Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4